Schubert & Co’s Biohaven BHVN Stock Holding History

Schubert & Co’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$69	–	209
2023 Q1	$69	Hold	5	–	–	﹤0.01%	1621
2022 Q4	$69	Buy	+5	New	+$71	﹤0.01%	1595

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Schubert & Co's BHVN Position: Q2 2023 in Review

Schubert & Co sold out of Biohaven (BHVN) in Q2 2023, closing a stake of 5 shares — an estimated $69 sold.

Schubert & Co first reported a position in BHVN in Q4 2022 and held it in 2 quarters. The position peaked at $69 in Q1 2023. 188 funds tracked by Wall St. Rank hold BHVN as of Q2 2023.

Schubert & Co reported no remaining Biohaven position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 5 Biohaven shares in Q2 2023, an estimated $69.
Schubert & Co first reported a position in Biohaven in Q4 2022 and held it in 2 quarters.
Schubert & Co's Biohaven position peaked at $69 in Q1 2023.
188 funds tracked by Wall St. Rank held Biohaven as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.